US Leading Index (M/M) Sep: 0.0% (est -0.1%; prev -0.1%)
US Leading Index (M/M) Sep: 0.0% (est -0.1%; prev -0.1%)
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
30 results loaded, newest first. More results are available. The latest changes are still being indexed. Try again shortly for updated results.
U.S. Stock Futures Fall as Tech Selloff and Oil Surge Weigh
U.S. stock futures fell early Thursday, with Nasdaq 100 futures down 1.33% and S&P 500 futures down 0.69%. Brent crude rose 2.03% to $111.03 a barrel as Middle East tensions and a tech-led selloff weighed on markets.
plc: Q3 2026 Trading Update
plc: Q3 2026 Trading Update Sustained high growth; strong customer adoption of our AI solutions; raising full-year guidance for revenue growth, EBITDA margins and cash flow; enhancing long-term growth with planned acquisitions of Octus and Trumid David Schwimmer, CEO said: “ record performance continued in Q3, with acc
Steel Dynamics Reports Q3 2026 Net Income of $756 Million
Steel Dynamics reported third-quarter net income of $756 million, or $5.26 per diluted share, and adjusted EBITDA of $1.2 billion. The company also reported record steel shipments of 3.8 million tons.
Organon Announces Positive Interim Phase 3 Study Results for MIUDELLA®, a Hormone — Free, Intrauterine Device (IUD), Through 6 Years of Use to Be Presented at the 2026 Society of Family Planning Annual Meeting
For best results when printing this announcement, please click on link below: Organon Announces Positive Interim Phase 3 Study Results for MIUDELLA(®), a Hormone-Free, Intrauterine Device (IUD), Through 6 Years of Use to Be Presented at the 2026 Society of Family Planning Annual Meeting No new safety signals identified
Home BancShares Reports Record Q3 Earnings and Higher Dividend
Home BancShares reported record third-quarter earnings and said it paid a new dividend of $0.23 per share, described as a 9.5% increase. The company also repurchased 1.3 million shares for approximately $39.3 million during the quarter.
WRAPUP 1 — US producer prices post largest gain in 4 — 1/2 years; retail sales beat expectations
( ) Producer Price Index surges 1.3% in September, largest gain since early 2022 Energy products lead rise, but other categories post price increases Higher gasoline prices boost retail sales; underlying sales slowing Weekly jobless claims remain below 200,000 level for fifth straight week By Lucia Mutikani WASHINGTON,
US Producer Prices Jump 1.3% in September, Exceeding Forecasts
U.S. producer prices rose 1.3% month over month in September, versus economists’ 0.5% estimate. Annual producer inflation accelerated to 6.3% from August’s revised 5.6%, the highest since December 2022.
Marsh Reports 8% Q3 Revenue Growth and Raises Savings Target
Marsh said third-quarter revenue rose 8% to $6.9 billion, underlying revenue growth was 5%, and adjusted EPS increased 10% to $2.03. The company raised its Thrive program savings target to $600 million from $400 million.
Howmet Raises 2026 Guidance After Q2 Revenue Rises 24%
Howmet Aerospace reported second-quarter revenue up 24% year over year, adjusted EPS up 46% to $1.33 and EBITDA margin up 340 basis points to 32.1%. The company raised its full-year revenue, EBITDA and EPS guidance.
EQS — News: Heidelberg Pharma Reports on the First Nine Months of Financial Year 2026
EQS-News: Heidelberg Pharma AG / Key word(s): 9 Month figures Heidelberg Pharma Reports on the First Nine Months of Financial Year 2026 15.10.2026 / 07:05 CET/CEST The issuer is solely responsible for the content of this announcement. ══════════════════════════════════════════════════════════════════════════ Heidelberg
Trulieve Reports Q2 Revenue of $271 Million, 60% Gross Margin
Trulieve reported second-quarter 2026 revenue of $271 million, a 60% gross margin and adjusted EBITDA of $98 million. The company said third-quarter revenue is expected to be comparable to the second quarter.
Trulieve Reports Q2 Revenue of $271 Million, Adjusted EBITDA of $98 Million
Trulieve reported second-quarter 2026 revenue of $271 million, a 60% gross margin and adjusted EBITDA of $98 million. Management said Q3 revenue is expected to be comparable to the medical-only business’s Q2 revenue of $222 million.
TKO Raises 2026 Guidance After Second-Quarter Revenue Rises 18%
TKO Group Holdings reported Q2 2026 revenue of $1.547 billion, up 18% year over year, and adjusted EBITDA of $650 million, up 23%. It raised full-year 2026 revenue guidance to $5.775 billion-$5.825 billion and adjusted EBITDA guidance to $2.275 billion-$2.305 billion.
StepStone Reports $106 Million in Q1 Fiscal 2027 Fee-Related Earnings
StepStone Group reported fee-related earnings of $106 million for the first quarter of fiscal 2027, up 30% year over year. It also reported a GAAP net loss of $116 million, which management attributed to fair-value changes related to the Private Wealth profits-interest buy-in.
Karman Holdings Q2 2026 Earnings Call Transcript
Karman Holdings (NYSE: KRMN ) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Karman Holdings reported a record secon
USDA lowers 2027 beef and pork production outlook
The USDA cut its 2027 U.S. beef production forecast to 24.7 billion pounds from 24.8 billion pounds and lowered pork output to 27.8 billion pounds from 28.1 billion pounds in the October WASDE report. Steer prices were unchanged at $2.38 a pound, while the barrows and gilts price estimate slipped to 63 cents from 64 ce
OTC Markets Gr Reports Q2 2026 Results: Full Earnings Call Transcript
On Thursday, OTC Markets Gr (OTC: OTCM ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary OTC Markets Group reported a record sec
Transcript: Tecnoglass Q2 2026 Earnings Conference Call
Tecnoglass (NYSE: TGLS ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summary Full Transcript OPERA
F&G Annuities & Life Reports Q2 2026 Results: Full Earnings Call Transcript
F&G Annuities & Life (NYSE: FG ) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary F&G Annuities & Life reported an 8% increase in As
U.S. natural gas falls after bigger-than-expected storage build
U.S. natural gas futures turned lower after the EIA reported a weekly inventory increase above expectations. The build left stocks at 3,500 Bcf, 68 Bcf above the 2021-2025 average.
Elanco Animal Health Reports Q2 2026 Results: Full Earnings Call Transcript
Elanco Animal Health (NYSE: ELAN ) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Full Transcript OPERATOR Good day and than
Saratoga Investment Reports Q2 2027 Results: Full Earnings Call Transcript
Saratoga Investment (NYSE: SAR ) released second-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summary Ful
Sourcelift releases AI Shelf Index on AI citations
Sourcelift said its Holiday 2026 AI Shelf Index found that a third of cited websites in its test were registered in the previous 12 months. It also said 72% of the answers with sources did not cite a brand's own website.
Seaport Therapeutics doses first patient in Phase 2a trial for anxiety drug GlyphAgo
Seaport Therapeutics has dosed the first patient in a Phase 2a clinical trial evaluating GlyphAgo (SPT-320), a novel prodrug of agomelatine, for adults with generalized anxiety disorder and sleep disturbance. Topline data from the trial are expected in early 2028.
Barings BDC Q2 2026 Earnings Call Transcript
Barings BDC (NYSE: BBDC ) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. View the webcast at Summary Barings BDC Inc. reported stro
Enact Holdings Q2 2026 Earnings Call Transcript
Enact Holdings (NASDAQ: ACT ) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered APIs. For comprehensive financial data and transcripts, visit The full earnings call is available at Summary Enact Holdings reported strong financi
Transcript: RXO Q2 2026 Earnings Conference Call
RXO (NYSE: RXO ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summary RXO reported strong Q2 2026 r
US stocks rally as cooler PCE inflation data fuels Fed rate cut hopes
US stock futures rose, with S&P 500 E-mini futures gaining about 0.4%, after the August PCE report showed inflation rose 0.3% month-on-month, below the 0.4% estimate. The annual rate was 2.6%, below the 3.7% forecast.
Africa Opportunity Fund reports half-yearly report for six months ended 30 June 2026
The fund said its unaudited half-year results were for the six months ended 30 June 2026. Ordinary share NAV per share was US$2.393 at 30 June 2026, up 58% from US$1.510 at 31 December 2025.